United KingdomOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,021 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 111,812 | 119,584 |
| Total Cites | 6,913 | 7,835 |
| H-index | 41 | 43 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 277 | 284 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 569 | 599 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2,270 | 2,437 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,795 | 6,133 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.28 |
| Self-Citation Percentage |
11.77%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,013 out of 148,458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 109,785 | 114,819 |
| Total Cites | 6,548 | 7,400 |
| H-index | 39 | 43 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 269 | 276 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 556 | 586 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 2,201 | 2,361 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,464 | 5,787 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.28 |
| Self-Citation Percentage |
11.51%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 939 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97,421 | 101,814 |
| Total Cites | 5,553 | 6,311 |
| H-index | 37 | 41 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 250 | 257 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 509 | 539 |
| Number of Single+First+Last Authored Papers | 39 | 39 |
| Total Cites to Single+First+Last Authored Papers | 1,953 | 2,098 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,586 | 4,873 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.30 |
| Self-Citation Percentage |
12.01%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 844 out of 94,611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,372 | 96,646 |
| Total Cites | 5,189 | 5,884 |
| H-index | 35 | 39 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 242 | 249 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 501 | 518 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 1,854 | 1,982 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,254 | 4,510 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.30 |
| Self-Citation Percentage |
11.81%
|
|
Trending Researchers
.jpeg)
Top 2% Scientists by Country
United Kingdom18,125 scientists, 3rd in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.